Overview

Safety Study of Pioglitazone Compared To Glyburide on Liver Function

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the liver safety of pioglitazone, once daily (QD), versus glyburide taken with metformin and insulin.
Phase:
Phase 4
Details
Lead Sponsor:
Takeda
Treatments:
Glyburide
Pioglitazone